Latest Breaking News On - Antiviral program for pandemics - Page 7 : comparemela.com

UNC-Chapel Hill secures $65 million NIH grant for establishing Antiviral Drug Discovery Center

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health awarded the UNC Gillings School of Global Public Health a $65 million grant establishing an Antiviral Drug Discovery Center to develop oral antivirals that can combat pandemic-level viruses like COVID-19.

North carolinaUnited statesChapel hillPardes biosciencesMark heiseTim willsonWilliamr kenan jrNathaniel moormanKevinm guskiewiczEmily hendersonGillings school of global public healthEshelman institute for innovationChimerix incSchool of medicineReaddi avidd centerAntiviral drug discovery center

PostEra spearheads AI-driven drug discovery collaboration to develop antiviral therapeutics with initial $68M in NIH funding – Padovanews

PostEra spearheads AI-driven drug discovery collaboration to develop antiviral therapeutics with initial $68M in NIH funding – Padovanews
padovanews.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from padovanews.it Daily Mail and Mail on Sunday newspapers.

United statesAlpha leeInfectious diseases antiviral program for pandemicsNational institutes of healthDrugs for neglected diseases initiativeAntiviral program for pandemicsMemorial sloan kettering cancer centerNational institutesNeglected diseases initiativeMemorial sloan kettering cancerNational instituteInfectious diseases antiviral programStructure enabled antiviral platformChief scientific officerAntiviral drug discoveryAntiviral program

NIH announces antiviral drug development awards

NIH announces antiviral drug development awards
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkMemorial sloan kettering cancer centerNew jerseyStanford universityHackensack university medical centerLa jollaSan franciscoAlpha leeAnthonys fauciPei yong shiJohn choderaJeffrey glennDavid perlinBen perryReuben harris

NIH awards $577 million to establish AViDD Centers for Pathogens of Pandemic Concern

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded approximately $577 million to establish nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.

United statesNew jerseyStanford universityHackensack university medical centerLa jollaSan franciscoAnthonys fauciEmily hendersonPei yong shiJeffrey glennDavid perlinReuben harrisNevan kroganRichard plemperSumit chandaUniversity of california

PostEra spearheads AI-driven drug discovery collaboration to develop antiviral therapeutics with initial $68M in NIH funding

BOSTON, May 18, 2022 /PRNewswire/ PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced a multi-year collaboration with the National

United statesPrnewswire posteraKostenloser wertpapierhandelAlpha leeInfectious diseases antiviral program for pandemicsNational institutes of healthDrugs for neglected diseases initiativeAntiviral program for pandemicsMemorial sloan kettering cancer centerNational institutesNeglected diseases initiativeMemorial sloan kettering cancerNational instituteInfectious diseases antiviral programStructure enabled antiviral platformChief scientific officer